293780.KQ
AptaBio Therapeutics Inc.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,620.00
+4.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.22x
- Price / sales
- 37.49x
- Price / cash flow
- -10.26x
Enterprise value
- Enterprise value
- KRW 167.6B
- EV / sales
- 35.26x
- EV / EBITDA
- -7.32x
- EV / EBIT
- -9.11x
- Market cap
- KRW 178.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026